以丰富供给壮大耐心资本

Core Insights - The article discusses the development of patient capital in China, emphasizing the need to enhance long-term capital supply in the capital market and optimize assessment mechanisms for patient capital [1][3][4]. Group 1: Patient Capital Development - The environment for patient capital, primarily focused on equity investment, has changed significantly in recent years, leading to rapid industry growth. However, private equity institutions in China face bottlenecks in fundraising, investment, management, and exit processes, which hinder the generation and expansion of patient equity capital [3][4]. - In 2024, the total amount pledged by national institutional LPs reached 1.27 trillion yuan, with 6,863 contributions made. Government funds played a crucial role, contributing 669.2 billion yuan, while financial institutions and social security funds contributed a total of 224.5 billion yuan, marking a 0.9 percentage point increase from 2023 [4][5]. Group 2: Investment Trends - There is a notable trend towards early-stage investments, with seed and startup project investment cases accounting for 41% in 2024, a 4 percentage point increase from 2021. Investments in angel, Pre-A, and A rounds collectively represent 66% of total investment cases [5][6]. - The focus of equity investment has shifted towards hard technology sectors, with IT, semiconductors, biotechnology/healthcare, and machinery manufacturing leading in both the number of investment cases and investment amounts, accounting for 74% and 63% respectively in 2024 [6]. Group 3: Policy Recommendations - To strengthen patient capital and increase long-term capital supply in the capital market, it is recommended to enhance the role of state-owned capital in equity investments. This includes optimizing the governance of government industry investment funds and integrating local government industry funds [7][8]. - Encouraging banks, insurance companies, and social security funds to enter the equity investment market is essential. This involves clarifying the usage scope and methods for these funds, simplifying investment decision-making processes, and enhancing risk management systems tailored to equity investment characteristics [8].